PE20030429A1 - Esteres de analogos de 3-desoxi-vitamina d3 - Google Patents
Esteres de analogos de 3-desoxi-vitamina d3Info
- Publication number
- PE20030429A1 PE20030429A1 PE2002000921A PE2002000921A PE20030429A1 PE 20030429 A1 PE20030429 A1 PE 20030429A1 PE 2002000921 A PE2002000921 A PE 2002000921A PE 2002000921 A PE2002000921 A PE 2002000921A PE 20030429 A1 PE20030429 A1 PE 20030429A1
- Authority
- PE
- Peru
- Prior art keywords
- deoxy
- vitamin
- esters
- inden
- octahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE REFIERE A ESTERES DE ANALOGOS DE 3-DESOXI-20-DESMETIL-20-CICLOPROPIL VITAMINA D3 DE FORMULA I DONDE L ES (CH2)3, -CH2-CH=CH-, (CH2)2-C=O, -CH=CH-CH=CH-; R2 Y R3 SON ALQUILO, HALOALQUILO; O R2 Y R3 JUNTO A C FORMAN CICLOALQUILO; R1 Y R4 SON H, ALQUILO, ACILO, GRUPO PROTECTOR DE HIDROXILO. SON COMPUESTOS PREFERIDOS [1R-(1O(E),3aß,7ao)]-OCTAHIDRO-7a-METIL-1-[5,5,5-TRIFLUORO-4-HIDROXI-4-(TRIFLUOROMETIL)-2-PENTINIL]CICLOPROPIL-4H-INDEN-4-OL; [1R-(1O(E),3aß,7Ao)]-OCTAHIDRO-7a-METIL-1-[1-[1-[5,5,5-TRIFLUORO-4-HIDROXI-4-(TRIFLUOROMETIL)-2-PENTINIL]CICLOPROPIL]-4H-INDEN-4-ONA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION; A UN METODO DONDE EL PACIENTE ES TRATADO ADEMAS CON UN BISFOSFONATO, ESTROGENO, AGENTE ANABOLIZANTE, MODULADOR SELECTIVO DE ESTROGENOS. LOS COMPUESTOS PUEDEN SER UTILES PARA EL TRATAMIENTO DEL INCREMENTO DE FORMACION OSEA, OSTEOPOROSIS, HIPERPARATIROIDISMO, OSTEODISTROFIA RENAL, OSTEOPOROSIS, EVITA O REDUCE LA INCIDENCIA DE FRACTURAS DEBIDO A LA DISMINUCION DE NIVELES DE ESTROGENOS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32387001P | 2001-09-21 | 2001-09-21 | |
| US32395701P | 2001-09-21 | 2001-09-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030429A1 true PE20030429A1 (es) | 2003-05-15 |
Family
ID=26984180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000921A PE20030429A1 (es) | 2001-09-21 | 2002-09-19 | Esteres de analogos de 3-desoxi-vitamina d3 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1430026A1 (es) |
| JP (1) | JP2005503434A (es) |
| KR (1) | KR100628586B1 (es) |
| CN (1) | CN1285573C (es) |
| AU (1) | AU2002338672B2 (es) |
| BR (1) | BR0212719A (es) |
| CA (1) | CA2459789A1 (es) |
| MX (1) | MXPA04002640A (es) |
| PA (1) | PA8554901A1 (es) |
| PE (1) | PE20030429A1 (es) |
| PL (1) | PL370352A1 (es) |
| RU (1) | RU2296121C2 (es) |
| UY (1) | UY27448A1 (es) |
| WO (1) | WO2003027065A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05003499A (es) * | 2002-10-23 | 2005-06-17 | Leo Pharma As | Analogos de vitamina d, composiciones que los comprenden y su uso. |
| WO2006036813A2 (en) * | 2004-09-24 | 2006-04-06 | Bioxell S.P.A. | 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof |
| US20080293647A1 (en) | 2004-11-12 | 2008-11-27 | Luciano Adorini | Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer |
| US9534907B2 (en) | 2008-08-22 | 2017-01-03 | Telit Automotive Solutions Nv | Location-based services |
| CN110339205B (zh) * | 2019-08-19 | 2021-08-24 | 山东德信生物科技有限公司 | 富氢水组合物在抑制六价铬诱导的df-1细胞内质网应激及自噬中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG70010A1 (en) * | 1996-05-23 | 2000-01-25 | Hoffmann La Roche | Fluorinated vitamin d3 analogs |
| DE69814109T2 (de) * | 1997-09-08 | 2004-02-26 | F. Hoffmann-La Roche Ag | 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga |
| US6331642B1 (en) * | 1999-07-12 | 2001-12-18 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
-
2002
- 2002-09-12 CN CNB028185285A patent/CN1285573C/zh not_active Expired - Fee Related
- 2002-09-12 EP EP02777075A patent/EP1430026A1/en not_active Withdrawn
- 2002-09-12 JP JP2003530656A patent/JP2005503434A/ja active Pending
- 2002-09-12 KR KR1020047004110A patent/KR100628586B1/ko not_active IP Right Cessation
- 2002-09-12 MX MXPA04002640A patent/MXPA04002640A/es active IP Right Grant
- 2002-09-12 WO PCT/EP2002/010233 patent/WO2003027065A1/en not_active Application Discontinuation
- 2002-09-12 AU AU2002338672A patent/AU2002338672B2/en not_active Ceased
- 2002-09-12 CA CA002459789A patent/CA2459789A1/en not_active Abandoned
- 2002-09-12 RU RU2004112217/04A patent/RU2296121C2/ru not_active IP Right Cessation
- 2002-09-12 PL PL02370352A patent/PL370352A1/xx not_active Application Discontinuation
- 2002-09-12 BR BR0212719-9A patent/BR0212719A/pt not_active IP Right Cessation
- 2002-09-18 PA PA20028554901A patent/PA8554901A1/es unknown
- 2002-09-19 PE PE2002000921A patent/PE20030429A1/es not_active Application Discontinuation
- 2002-09-20 UY UY27448A patent/UY27448A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04002640A (es) | 2004-06-07 |
| CA2459789A1 (en) | 2003-04-03 |
| UY27448A1 (es) | 2003-03-31 |
| EP1430026A1 (en) | 2004-06-23 |
| KR20040035853A (ko) | 2004-04-29 |
| AU2002338672B2 (en) | 2006-03-09 |
| WO2003027065A1 (en) | 2003-04-03 |
| KR100628586B1 (ko) | 2006-09-26 |
| BR0212719A (pt) | 2004-08-03 |
| CN1556795A (zh) | 2004-12-22 |
| RU2296121C2 (ru) | 2007-03-27 |
| PL370352A1 (en) | 2005-05-16 |
| RU2004112217A (ru) | 2005-07-10 |
| CN1285573C (zh) | 2006-11-22 |
| PA8554901A1 (es) | 2003-12-10 |
| JP2005503434A (ja) | 2005-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20011104A1 (es) | Un proceso para la preparacion de analogos de epotilona | |
| PE20020593A1 (es) | Activadores de glucocinasa del tipo isoindolin-2-ona | |
| RU94044671A (ru) | Применение непептидных антагонистов рецептора тахикинина | |
| DE60307607D1 (de) | Verwendung von selektiven ep4 rezeptor agonisten zur behandlung von krankheiten | |
| ATE331713T1 (de) | Verfahren zur herstellung von 5-nitrobenzofuranen | |
| CY1111396T1 (el) | Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης | |
| PE20010402A1 (es) | Derivados de 1,5-dihidropirrol-2-ona sustituida | |
| SE8704248D0 (sv) | Medical use | |
| PE20030429A1 (es) | Esteres de analogos de 3-desoxi-vitamina d3 | |
| IL162614A (en) | Alpha tocopherol esters for use in treating culture-borne cell disease by aerosol administration | |
| ES2064661T3 (es) | 11-ceto o hidroxi-3,5-dieno-esteroides como inhibidores de esteroide-5-alfa-reductasa. | |
| NO995843D0 (no) | Farmasöytisk preparat omfattende vWF-propeptid | |
| RU2019119778A (ru) | Применение цементов на основе оксидов металлов | |
| ES2202156T3 (es) | Nuevos analogos de 2-descarboxi-2-fosfinico prostaglandina f. | |
| CO5160251A1 (es) | Analogos de prostaglandinas selectivos del receptor fp c16 insaturados | |
| ATE26273T1 (de) | 3-indolcarboxamid-verbindungen. | |
| EP0269311A3 (en) | Methods of treating bone diseases by administration of a cysteine proteinase inhibitor | |
| WO2001014360A3 (en) | Benzopyrans and benzothiopyrans as rar selective retinoid agonists | |
| IS8306A (is) | Augnsamsetningar til að meðhöndla aungháþrýsting | |
| US5149536A (en) | Dental root canal bacterialcidal lubricant | |
| CA1305420C (en) | Pharmaceutical preparation having antihypertensive activity | |
| DE60121459D1 (de) | Cyanidinmischung zur behandlung von dickdarmkrebs | |
| AR040202A1 (es) | Combinacion de un agente inhibidor de la secrecion de acido y un inhibidor de reflujo para el tratamiento de la gerd | |
| KR910007887A (ko) | W-페녹시-헤테로사이클릭 화합물 | |
| ATE289817T1 (de) | Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |